Kardiochirurgia i Torakochirurgia Polska

Abstract

4/2023 vol. 20
Review paper

Radiotherapy for tumors of the mediastinum – state of the art

  1. First Department of Radiotherapy, ‘Metaxa’ Cancer Hospital, Piraeus, Greece
  2. Second Department of Radiology, ‘Attikon’ University Hospital, Athens, Greece
  3. Medical Physics Department, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece
  4. Department of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, Germany
  5. Department of Thoracic Surgery and Thoracic Endoscopy, University Medicine Essen – Ruhrland Clinic, Essen, Germany
  6. Department of Cardiothoracic Surgery, University Hospital of Patras, Patras, Greece
  7. Department of Surgery, University Hospital of Patras, Patras, Greece
  8. Department of Thoracic Surgery, ‘Metaxa’ Cancer Hospital, Piraeus, Greece
Kardiochirurgia i Torakochirurgia Polska 2023; 20 (4): 255-262
Online publish date: 2024/01/11
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Mediastinal tumors encompass a diverse range of malignancies, originating within or spreading to the mediastinum. The administration of radiotherapy within the anatomical confines of the mediastinum presents unique challenges owing to the close proximity of critical organs, including the heart, lungs, esophagus, and spinal cord. However, recent progress in imaging techniques, treatment modalities, and our understanding of tumor biology has significantly contributed to the development of effective and safe therapeutic strategies for mediastinal diseases. This review article aims to explore the latest innovations in radiotherapy and their practical applications in the management of mediastinal tumors, with a primary focus on lymphomas, thymomas, and thymic carcinomas. By examining these advancements, we seek to provide valuable insights into the current state of the art in radiotherapy for mediastinal malignancies, ultimately fostering improved patient outcomes and clinical decision-making.
Share
without publication fees
without publication fees